The Official Medicare Set Aside Blog And Information Resource

MSP Compliance Continues to be Placed at the Forefront

Conditional Payments, Medicare, MSP News on March 20, 2019
Posted by Jean S. Goldstein, JD

On Monday, the U.S. Department of Justice’s (DOJ) Attorney’s Office for the District of Maryland issued a press release concerning a settlement arrangement involving the repayment of conditional payments with the law firm of Meyers, Rodbell & Rosenbaum, P.A., a firm based out of Maryland.  The law firm entered into the settlement agreement to resolve […] Continue

MSPRP E-Payments Go Live On April 1, 2019

CMS, Conditional Payments, Medicare Secondary Payer Recovery Portal on March 14, 2019
Posted by Jean S. Goldstein, JD

Yesterday, the Centers for Medicare and Medicaid Services (CMS) held a high level overview webinar of changes coming to the Medicare Secondary Payer Recovery Portal (MSPRP), as we recently discussed here on our blog.  The webinar addressed the most recent upcoming enhancement, which will allow electronic payments to be submitted directly through the MSPRP.  As […] Continue

FDA Approves Esketamine Nasal Spray (Spravato™) for Treatment-Resistant Depression

FDA, MSAs, Rx/Pharmacy on March 13, 2019
Posted by Leah King, PharmD, JD, Pharmacy Consultant

Earlier this month, the Food and Drug Administration (FDA) approved esketamine nasal spray, which will be marketed by Johnson & Johnson (J&J) under the trade name of Spravato™. Spravato is approved for use in conjunction with an oral antidepressant for treatment-resistant depression. The term “treatment-resistant” refers to those patients who have failed to achieve relief […] Continue

Efforts to Streamline the Conditional Payment Recovery Process Continue, Amidst Confirmation of Ramp up from the CRC

CMS, Conditional Payments, Medicare Secondary Payer Recovery Portal on March 5, 2019
Posted by Jean S. Goldstein, JD

Last week, the Centers for Medicare & Medicaid Services (CMS) announced two upcoming webinars, aimed at addressing payment functionalities within both the Medicare Secondary Payment Recovery Portal (MSPRP) and Commercial Repayment Center Portal.  These latest enhancements to the conditional payment recovery process will enable users of the CMS maintained portals to make electronic payments for […] Continue

Osteoarthritis Drug Receives Fast Track Designation from FDA

FDA, MSAs, Rx/Pharmacy on February 21, 2019
Posted by Leah King, PharmD, JD and Marilyn J. Larrimer, RN, BSN, JD

In late November 2018, the FDA announced that it was granting Fast Track designation to an investigational drug for the treatment of osteoarthritis (OA). The drug, developed by Galapagos, is known by its identifier GLPG1972/S201086.  This drug is one to watch, since it has a novel mechanism of action for this therapeutic category. GLPG1972/S201086 is […] Continue